Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
James M. Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
The Lancet (2020) Vol. 395, Iss. 10231, pp. 1217-1224
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
Jaideep Kapur, Jordan Elm, James M. Chamberlain, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 22, pp. 2103-2113
Open Access | Times Cited: 450
European Resuscitation Council Guidelines 2021: Paediatric Life Support
Patrick Van de Voorde, Nigel M. Turner, Jana Djakow, et al.
Resuscitation (2021) Vol. 161, pp. 327-387
Closed Access | Times Cited: 315
National UK programme of community health workers for COVID-19 response
Andy Haines, Enrique Barros, Anita Berlin, et al.
The Lancet (2020) Vol. 395, Iss. 10231, pp. 1173-1175
Open Access | Times Cited: 229
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Wolfgang Löscher, Pavel Klein
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 935-963
Open Access | Times Cited: 217
Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial
Stuart R Dalziel, Meredith L Borland, Jeremy Furyk, et al.
The Lancet (2019) Vol. 393, Iss. 10186, pp. 2135-2145
Closed Access | Times Cited: 202
Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest
Barry J. Ruijter, Hanneke M. Keijzer, Marleen C. Tjepkema‐Cloostermans, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 724-734
Open Access | Times Cited: 115
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial
Abhishek G. Sathe, Ellen Underwood, Lisa D. Coles, et al.
Epilepsia (2021) Vol. 62, Iss. 3, pp. 795-806
Open Access | Times Cited: 65
Why won’t it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J. Burman, Richard Rosch, Jo M. Wilmshurst, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 428-441
Closed Access | Times Cited: 63
Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks
Johannes Jungilligens, R. Michaelis, Stoyan Popkirov
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 92, Iss. 12, pp. 1341-1345
Open Access | Times Cited: 59
Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children
Mohammad Kurd, Saar Hashavya, Shmuel Benenson, et al.
Seizure (2021) Vol. 92, pp. 89-93
Open Access | Times Cited: 59
Recent advances in pharmacotherapy for epilepsy
Amanda W. Pong, Kevin J. Xu, Pavel Klein
Current Opinion in Neurology (2023) Vol. 36, Iss. 2, pp. 77-85
Closed Access | Times Cited: 40
Ketamine as advanced second‐line treatment in benzodiazepine‐refractory convulsive status epilepticus in children
Silvia Buratti, Emanuele Giacheri, Antonella Palmieri, et al.
Epilepsia (2023) Vol. 64, Iss. 4, pp. 797-810
Open Access | Times Cited: 23
Use of Benzodiazepines in Patients with Status Epilepticus Requiring Second-line Antiseizure Medication Treatment
Teemu Pöytäkangas, Pabitra Basnyat, Sirpa Rainesalo, et al.
Epilepsy Research (2025) Vol. 210, pp. 107507-107507
Open Access | Times Cited: 1
Lebensrettende Maßnahmen bei Kindern (Paediatric Life Support, PLS)
Patrick Van de Voorde, Nigel M. Turner, Jana Djakow, et al.
Notfall + Rettungsmedizin (2021) Vol. 24, Iss. 4, pp. 650-719
Open Access | Times Cited: 42
Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials
Markus Leitinger, Nicolas Gaspard, Lawrence J. Hirsch, et al.
Epilepsia (2023) Vol. 64, Iss. 9, pp. 2351-2360
Open Access | Times Cited: 19
Challenges of Delirium Management in Patients with Traumatic Brain Injury: From Pathophysiology to Clinical Practice
Shawniqua Williams Roberson, Mayur B. Patel, Wojciech Dąbrowski, et al.
Current Neuropharmacology (2021) Vol. 19, Iss. 9, pp. 1519-1544
Open Access | Times Cited: 33
Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic
Doodipala Samba Reddy
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 273-300
Open Access | Times Cited: 16
Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion
Adriana Celdran de Castro, Fábio A. Nascimento, Álvaro Beltrán‐Corbellini, et al.
Seizure (2023) Vol. 107, pp. 121-131
Open Access | Times Cited: 14
Diagnosis and management of status epilepticus: improving the status quo
Jennifer V. Gettings, Fatemeh Mohammad Alizadeh Chafjiri, Archana A. Patel, et al.
The Lancet Neurology (2024)
Closed Access | Times Cited: 5
Diagnosis and Treatment of Status Epilepticus
Sang Kun Lee
Journal of Epilepsy Research (2020) Vol. 10, Iss. 2, pp. 45-54
Open Access | Times Cited: 34
Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management
Batool Kirmani, Katherine Au, Lena Ayari, et al.
Aging and Disease (2021) Vol. 12, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 31
Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors
Lucille A. Lumley, Jérôme Niquet, Brenda Marrero‐Rosado, et al.
Neuropharmacology (2021) Vol. 185, pp. 108444-108444
Open Access | Times Cited: 29
World Federation of Neurology Needs Registry Survey 2021
William W. Carroll, Wolfgang Grisold
Journal of the Neurological Sciences (2024) Vol. 465, pp. 123124-123124
Closed Access | Times Cited: 4
Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist
Jason Katz, Kent A. Owusu, Ilisa Nussbaum, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 881-881
Open Access | Times Cited: 24
Tenets of timing: An evidence-based comprehensive review on time-lag in the management of pediatric status epilepticus and its effect on clinical outcomes
Vaibhav Rajendra Suryawanshi, Kavita Srivastava, Asawari Raut, et al.
Epilepsy Research (2025), pp. 107518-107518
Closed Access
Page 1 - Next Page

Scroll to top